V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009329 | 310004316 | null | null | null | 2017-10-17 | 2017-10-17 | Brentuximab | 2 | N | 310016212 | BRENTUXIMAB |
| 310009330 | 310004318 | 1.85 | null | null | 2019-07-21 | 2019-08-12 | GEMCITABINE | 02 | N | 310016231 | GEMCITABINE |
| 310009331 | 310004322 | 1.81 | 89 | Curative (C) | null | 2014-03-22 | Brentuximab | null | null | 310016285 | BRENTUXIMAB |
| 310009332 | 310004323 | 1.81 | 76.9 | null | 2017-02-18 | 2017-02-26 | BEAM | N | N | 310016301 | BEAM |
| 310009333 | 310004325 | 1.82 | null | Curative (C) | 2013-11-24 | 2013-11-24 | GEM-P | 2 | N | 310016303 | GEMCITABINE + PACLITAXEL |
| 310009334 | 310004330 | 1.75 | 140.6 | Palliative (P) | 2018-09-16 | 2018-10-22 | Brentuximab | N | N | 310016356 | BRENTUXIMAB |
| 310009335 | 310004331 | 1.64 | 70 | Curative (C) | 2014-04-09 | 2014-05-01 | GEM-P | 2 | N | 310016377 | GEMCITABINE + PACLITAXEL |
| 310009336 | 310007814 | 1.54 | 47.2 | Curative (C) | 2016-03-05 | 2016-03-05 | Olaratumab | N | null | 310016471 | NOT MATCHED |
| 310009338 | 310004342 | 1.91 | 89 | null | 2014-08-30 | 2014-08-30 | CISPLATIN + GEMCITABINE | 2 | N | 310016481 | CISPLATIN + GEMCITABINE |
| 310009339 | 310004342 | 1.78 | 63.9 | Disease modification (D) | 2018-11-02 | 2018-11-12 | GEM-P | 2 | N | 310016481 | GEMCITABINE + PACLITAXEL |
| 310009340 | 310004343 | 1.57 | 58.9 | Palliative (P) | 2018-08-20 | 2018-08-20 | PEMBROLIZUMAB | Y | N | 310016521 | PEMBROLIZUMAB |
| 310009341 | 310004343 | 1.68 | 66.2 | Adjuvant (A) | 2017-04-30 | 2017-08-21 | CISPLATIN + GEMCITABINE | N | N | 310016521 | CISPLATIN + GEMCITABINE |
| 310009342 | 310004346 | 1.74 | 62 | Palliative (P) | null | 2015-09-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016629 | CISPLATIN + GEMCITABINE |
| 310009343 | 310004350 | 1.68 | 53.1 | Curative (C) | 2015-05-27 | 2016-09-13 | IVE | 2 | N | 310016633 | IVE |
| 310009344 | 310004351 | 1.56 | 56 | Palliative (P) | 2016-07-07 | 2016-07-07 | Carboplatin + Liposomal Doxorubicin | N | N | 310016650 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009345 | 310004354 | 1.59 | null | Curative (C) | 2017-10-29 | 2017-11-04 | CISPLATIN + GEMCITABINE | N | N | 310016669 | CISPLATIN + GEMCITABINE |
| 310009346 | 310004356 | 1.57 | 61.5 | Palliative (P) | null | 2015-09-01 | Gemcitabine weekly | 02 | Y | 310016672 | GEMCITABINE |
| 310009347 | 310004357 | 1.53 | 57 | Curative (C) | 2014-09-03 | 2014-09-07 | BEAM | N | N | 310016672 | BEAM |
| 310009348 | 310004357 | 1.81 | 67.3 | Curative (C) | 2016-03-17 | 2016-03-20 | CISPLATIN + GEMCITABINE | N | null | 310016672 | CISPLATIN + GEMCITABINE |
| 310009349 | 310004358 | null | 84.3 | null | 2018-11-01 | 2018-11-05 | GEMCITABINE | N | N | 310016746 | GEMCITABINE |
| 310009350 | 310004358 | 1.72 | 67.7 | Curative (C) | 2017-07-14 | 2017-07-18 | BEAM | 2 | null | 310016746 | BEAM |
| 310009351 | 310004359 | null | 58.3 | Disease modification (D) | 2018-01-21 | 2018-01-24 | BEAM | N | N | 310016778 | BEAM |
| 310009352 | 310004361 | 1.73 | 82.6 | Curative (C) | 2016-08-22 | 2016-08-29 | IVE | N | N | 310016795 | IVE |
| 310009353 | 310004362 | 1.84 | 74.8 | Adjuvant (A) | 2018-07-29 | 2018-07-29 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310016799 | GEMCITABINE |
| 310009354 | 310004364 | 1.7 | 67.9 | Palliative (P) | 2015-08-05 | 2015-09-04 | Gemcitabine day 1&8 | N | N | 310016833 | GEMCITABINE |
| 310009355 | 310004369 | 1.63 | 111.9 | Palliative (P) | 2018-04-04 | 2018-10-06 | Carboplatin + Liposomal Doxorubicin | Y | N | 310016840 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009356 | 310007828 | 1.75 | 95.2 | Curative (C) | 2015-12-03 | 2016-05-13 | Brentuximab | 2 | N | 310016840 | BRENTUXIMAB |
| 310009357 | 310004372 | null | 89.6 | Curative (C) | 2015-10-25 | 2016-02-08 | IVE | N | Y | 310016856 | IVE |
| 310009358 | 310007830 | 1.8 | 84.4 | Palliative (P) | 2016-08-24 | 2016-08-29 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310016872 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009359 | 310004374 | 1.65 | null | Palliative (P) | 2014-12-16 | 2014-12-20 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310016876 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009360 | 310004377 | 1.68 | 76.8 | null | 2017-12-09 | 2017-12-09 | ALL Int GdeC AugBFMCon PhII pt1PAsp | 02 | N | 310016885 | NOT MATCHED |
| 310009361 | 310009680 | 0 | 68.5 | Curative (C) | 2018-11-15 | 2018-11-24 | CNS Pineoblastoma guidelines Vinc/Etop/Cyclophos | N | N | 310016898 | NOT MATCHED |
| 310009362 | 310007833 | 1.71 | 57.4 | Palliative (P) | 2017-07-26 | 2017-07-26 | Gemcitabine + Paclitaxel | N | N | 310016909 | GEMCITABINE + PACLITAXEL |
| 310009363 | 310004380 | 1.65 | 14 | Disease modification (D) | 2014-08-02 | 2014-08-03 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 310016920 | GEMCITABINE |
| 310009364 | 310004382 | 1.5 | 63 | Palliative (P) | 2015-07-10 | 2016-04-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016931 | CISPLATIN + GEMCITABINE |
| 310009365 | 310004385 | null | 56.1 | null | 2013-10-11 | 2013-10-11 | Brentuximab | N | N | 310016946 | BRENTUXIMAB |
| 310009366 | 310004385 | 1.59 | 60.1 | Curative (C) | 2017-08-15 | 2017-08-22 | null | 02 | N | 310016946 | NOT MATCHED |
| 310009367 | 310004385 | null | 88.6 | Palliative (P) | 2017-05-03 | 2017-05-05 | GEM-P | N | N | 310016946 | GEMCITABINE + PACLITAXEL |
| 310009369 | 310004390 | 1.61 | 71.5 | Palliative (P) | 2018-05-08 | 2018-05-22 | Brentuximab Vedotin | 02 | N | 310017045 | BRENTUXIMAB |
| 310009370 | 310004392 | 1.54 | 70 | Palliative (P) | 2015-07-21 | 2015-07-21 | Carboplatin + Liposomal Doxorubicin | N | N | 310017080 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009371 | 310004395 | 1.57 | 60 | Curative (C) | 2013-09-06 | 2014-03-16 | IVE | null | null | 310017082 | IVE |
| 310009372 | 310007845 | 1.56 | 47.2 | Palliative (P) | 2016-09-08 | 2016-09-19 | PEMBROLIZUMAB | 2 | N | 310017154 | PEMBROLIZUMAB |
| 310009373 | 310004398 | 1.75 | 83 | Palliative (P) | 2015-12-07 | 2016-06-08 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310017155 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009374 | 310004400 | null | 78.8 | null | 2017-08-05 | 2017-08-05 | GEM-P | 2 | N | 310017180 | GEMCITABINE + PACLITAXEL |
| 310009375 | 310004403 | 1.53 | 70 | Curative (C) | 2015-06-10 | 2015-06-24 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | 310017198 | NOT MATCHED |
| 310009376 | 310004406 | 1.67 | 103 | Curative (C) | 2017-04-25 | 2017-05-07 | IVE | 02 | N | 310017235 | IVE |
| 310009377 | 310009687 | 1.69 | 79 | Palliative (P) | 2017-11-07 | 2017-11-21 | Carboplatin + Liposomal Doxorubicin | N | N | 310017252 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009378 | 310004410 | null | 100 | null | null | 2015-02-26 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310017258 | CISPLATIN + GEMCITABINE |
| 310009379 | 310004412 | 1.75 | 14.4 | Curative (C) | 2014-08-27 | 2014-08-27 | Brentuximab | N | N | 310017269 | BRENTUXIMAB |
| 310009380 | 310004413 | 1.51 | 68.6 | Palliative (P) | 2014-07-12 | 2014-07-27 | Carboplatin + Liposomal Doxorubicin | N | null | 310017276 | CARBOPLATIN + LIPOSOMAL DOX |